Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
60.09
+0.73 (1.23%)
Nov 21, 2024, 12:23 PM EST - Market open
Rhythm Pharmaceuticals Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for RYTM stock have an average target of 62.3, with a low estimate of 52 and a high estimate of 80. The average target predicts an increase of 3.68% from the current stock price of 60.09.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RYTM stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 5 | 6 |
| Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 8 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $80 | Strong Buy | Maintains | $80 | +33.13% | Nov 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $64 → $69 | Strong Buy | Maintains | $64 → $69 | +14.83% | Nov 7, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $77 → $80 | Strong Buy | Maintains | $77 → $80 | +33.13% | Nov 6, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $55 → $65 | Strong Buy | Maintains | $55 → $65 | +8.17% | Nov 6, 2024 |
| Needham | Needham | Strong Buy Maintains $55 → $64 | Strong Buy | Maintains | $55 → $64 | +6.51% | Nov 6, 2024 |
Financial Forecast
Revenue This Year
126.94M
from 77.43M
Increased by 63.95%
Revenue Next Year
181.83M
from 126.94M
Increased by 43.24%
EPS This Year
-4.50
from -3.20
EPS Next Year
-2.73
from -4.50
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 133.2M | 219.0M | 491.4M | ||
| Avg | 126.9M | 181.8M | 335.5M | ||
| Low | 120.7M | 161.4M | 214.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 72.1% | 72.5% | 170.3% | ||
| Avg | 63.9% | 43.2% | 84.5% | ||
| Low | 55.9% | 27.1% | 17.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -4.22 | -2.13 | 1.54 | ||
| Avg | -4.50 | -2.73 | -1.02 | ||
| Low | -4.57 | -3.10 | -2.76 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.